Rate of weight gain (g/kg/day) · preterm infants
1 finding from 1 review
Linear growth (cm/week) · preterm infants
1 finding from 1 review
Growth velocity, head circumference, mm/d, end of intervention · preterm infants
1 finding from 1 review
Neurodevelopmental outcomes · preterm infants
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Duration of hospital admission (days) · preterm infants
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Feeding intolerance · preterm infants
It is very uncertain whether fat supplementation changes feeding intolerance compared with control (very low certainty).
1 finding from 1 review
Necrotising enterocolitis · preterm infants
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Biochemical markers of essential fatty acid status: EPA and DHA % content of neutrophil membrane · adults and children with cystic fibrosis
1 finding from 1 review
Language development ‐ Beyond 24 months · Breastfeeding mothers
1 finding from 1 review
Intelligence or problem‐solving ability ‐ Beyond 24 months · Breastfeeding mothers
1 finding from 1 review
Psychomotor development · Breastfeeding mothers
1 finding from 1 review
Attention · Breastfeeding mothers
1 finding from 1 review
Visual acuity · Breastfeeding mothers
1 finding from 1 review
Child weight ‐ Long term beyond 24 months · Breastfeeding mothers
1 finding from 1 review
Fatal or nonfatal myocardial infarction · middle‐aged US male physicians
Vitamin C supplementation showed no clear difference in total myocardial infarction (fatal and non‐fatal) Physicians compared with placebo (low certainty).
1 finding from 1 review
Stroke · middle‐aged US male physicians
Vitamin C supplementation showed no clear difference in total stroke (fatal and non‐fatal) Physicians compared with placebo (low certainty).
1 finding from 1 review
Pulmonary exacerbations · adults and children with cystic fibrosis
1 finding from 1 review
Diarrhoea · adults and children with cystic fibrosis
It is very uncertain whether summary of findings: omega‐3 fatty acid supplementation changes adverse events: diarrhoea compared with placebo (very low certainty).
1 finding from 1 review
FEV1 % predicted · adults and children with cystic fibrosis
It is very uncertain whether summary of findings: omega‐3 fatty acid supplementation changes FEV1 % predicted compared with placebo (very low certainty).
1 finding from 1 review
FVC · adults and children with cystic fibrosis
It is very uncertain whether summary of findings: omega‐3 fatty acid supplementation changes FVC % predicted compared with placebo (very low certainty).
1 finding from 1 review